tirzepatide risk of cancer Popular obesity medications significantly lower overall risk, study finds. The breakthrough class obesity medications, including GLP-1 receptor agonists like semaglutide and dual GLP-1/GIP receptor agonists like tirzepatide, continue to make Weight-loss drugs may lower cancer

Q2: Is Retatrutide better than semaglutide for weight loss

The clinical evidence base for these agents, both individually and in combination, is still emerging

Talk to your healthcare provider about the best weight management solution for you

Whether you take GLP-1 medications or focus on lifestyle changes, our team supports you with expertise and encouragement

Many people experience excellent results when taking semaglutide and even see improvements in weight-related health issues in addition to dropping extra pounds

MNT had the opportunity to speak with Anton Bilchik, MD, PhD, a surgical oncologist, chief of medicine and director of the Gastrointestinal and Hepatobiliary Program at Providence Saint Johns Cancer Institute in Santa Monica, CA, about this study